1. Kamath S. Hypertension in pregnancy. JAPL 2006; 54: 269-270
2. Dutta D.C (2001), Hypertensive disorders in pregnancy, in :Textbook of obstetrics, Ed. Konar, H.L., 5th edition,234-55
3. Packer CS. Biochemical markers and physiological parameters as indices for identifying patients at risk of developing pre-eclampsia. J Hypertens 2005;23:(1)45-6.
4. Herrera, E (2002). Lipid metabolism in pregnancy and its consequences in the fetus and newborn. Endocrine 19 43 - 55.
5. Enquobahrie DA, Williams MA, Butler CL, Frederick IO, Miller RS, Luthy DA. Maternal plasma lipid concentrations in early pregnancy and risk of preeclampsia. Am J Hypertens 2004; 17(7): 574-581.
6. Gratacos E, Casals E, Gomez O, Llurba E, Mercador I, Cararach V, Cabero L. Increased susceptibility to low density lipoprotein oxidation in women with a history of preeclampsia. Br J of Obstet Gynaecol 2003; 110(4): 400-4
7. K. Yagi, Assay for lipid peroxide level and its clinical significance, in: Lipid Peroxides in Biology and Medicine, New York. 1982; 233¬242.
408
www.ijbamr.com
Indian Journal of Basic & Applied Medical Research; December 2012: Issue-5, Vol.-2, P. 405-409
8. Khong TY, DE Wolf, Robetson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small for gestational age infants. Br J Obstet Gynaecol 1986;93:1049-1059.
9. Broughton Pipkin F. What is the place of genetics in the pathogenesis of pre-eclampsia? Biol Neonate
1999;76:325-330.
10. Chiang,A.N.,Yang, M.L.,Hung, J.H., Chon, P., Shyn, S.K. and Ng,H.T.(1995).Alteration of serum lipid levels and their biological relevances during and after pregnancy.Life sci. 56(26),2367-75.
11. Glueck, C.J.,Fallet, R.W. and Scheel, D.(1975) Effects of oestrogenic compounds on triglyceride kinetics.Metabolism 24, 537-45.
12. Kaaja R. Insulin resistance syndrome in pre-eclampsia. Sem Reprod Endocrinol 1998; 16: 41-6.
13. Kaaja R., Tikkanen MJ. (1995) Serum lipoproteins, insulin and urinary prostanoid metabolites in normal and hypertensive pregnant women.Obstet. Gynecol 1995;85(3):253-6.
14. Patrizia B, Giancarlo T, Franca E, et al. Lipoprotein metabolism during normal pregnancy. Am J Obstet Gynecol
1999; 181(2): 430-4.
15. Rubina A, Tabassum M. Pre-eclampsia and lipid profile. Pak J Med Sci 2007; 23: 751-4
16. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-26.
17. Cekmen, M.B.,Erbagci, A.B.(2003) plasma lipid and lipoprotein concentration in pregnancy induced hypertention,Clin. Biochem.36(7),575-8.
18. Pirzado ZA, Sangi SA, Malik R. High density lipoprotein cholesterol (HDL) metabolism and its role in the
ischemic heart disease. Pak J Med Res 1999; 38: 38-41.
19. Wakatsuki A, Ikenoue N, Okatani Y, Shinohara K, Fukaya T. Lipoprotein particles in preeclamsia: Sucsceptibility to oxidative modification. Obstet Gynecol 2000; 96(1): 55-5
20. Lorensten, B. and Henriksen, T.(1998)Plasma lipids and vascular dysfunction in pre-eclampsia.
Thank you for copying data from http://www.arastirmax.com
